View on market: Stay Cautious, be with quality business:

Asian stocks tracked U.S. declines Wednesday as concern about faster inflation shadows the economic recovery from the pandemic. A dollar gauge was near the lowest level this year. Japanese and Australian shares slid after key U.S. equity benchmarks closed lower and large technology stocks like Amazon.com Inc. and Microsoft Corp. erased gains. Contracts on the S&P 500 and Nasdaq 100 were in the red.

The Singapore-traded SGX Nifty, an early indicator of India’s Nifty 50 Index’s performance, fell 0.64% to 15,063.0 as of 7:55 a.m.

A slide in crude on the possibility of more supply from Iran hurt energy stocks overnight. Treasury yields were steady.

Key Data/ Action, Result, and Board meeting to watch

Major economic Data:

  • INR: Deposit Growth YoY MAY on 21st May, 2021
  • INR: Bank Loan Growth YoY MAY on 21st May, 2021
  • USD: FOMC Meeting Minutes on 19th May, 2021
  • USD: Crude oil Inventories on 19th May,2021

Non-Nifty Results: Angel, Endurance, JKTYRE, IRFC, PRSM Johnson, IOC,Gravita, Heritage Food,

International Markets:

U.S & Europe

Particulars    18th May. Chg Chg(%)
Nasdaq 13,303.64 -75.41 -0.56
Dow 34060.66 -267.13 0.78
FTSE 7,034.24 1.39 0.02
CAC 6,353.67 -13.68 -0.21
DAX 15,386.58 -10.04 -0.07
Dow Fut.* 33,895.00 -101 -0.3

Asian markets:

Particulars    19th May. Chg Chg(%)
SGX Nifty 15,063.00 -97.5 -0.64
Nikkei 27,977.84 -429 -1.51
Straits Times 3,130.16 -12.47 -0.4
Hang Seng 28,593.81 399.72 1.42
Shanghai 3,510.17 -18.84 -0.53

ADR Watch:

Particulars       18th May. Chg Chg(%)
Dr Reddy 71.75 -0.25 -0.35
HDFC Bank 73.99 2.34 3.27
ICICI Bank 17.18 0.13 0.76
Infosys 18.26 0.09 0.50
Tata Motor 21.91 0.01 0.05
Wipro 7.45 0.14 1.92

Commodities & Currency

Particulars Current Price Chg(%)
USD/INR 73.05 -0.23
Brent 68.02 -1.00
Gold 1866.80 -0.06
Silver 28.073 -0.92

FIIs & DII

Particulars   18th May. 17th May.
FIIs 618.49 -2255.84
DIIs 449.52 1948.48

Results:

Tata Motors Q4FY21 (Consolidated, QoQ) Revenue up 17% at Rs 88,628 crore Vs Rs 75,654 crore (Bloomberg estimate: Rs 87,517 crore) Net loss of Rs 7,585 crore Vs Net profit of Rs 2,941 crore (estimate: Rs 2,774 crore Profit) Ebitda at Rs 12,745 crore Vs 11,509 crore (estimate :Rs 11,210 crore) Margins at 14.4% Vs 15.2% (estimate: 12.8%)

Torrent Pharmaceuticals Q4FY21 (Consolidated, QoQ) Revenue down 3% at Rs 1,937 crore Vs Rs 1,995 crore Net profit up 9% at Rs 324 crore Vs Rs 297 crore Ebitda down 4% at Rs 582 crore Vs Rs 607 crore Ebitda Margins at 30% vs 30.4% Recommended a final dividend of Rs 15 per share Had one-time tax benefit of Rs 53 crore under the CARES Act enacted by the U.S. Government in March 2020 in response to Covid -19 pandemic To raise up to Rs 5000 crore via issuance of shares

GlaxoSmithKline Pharmaceuticals Q4FY21 (Consolidated, QoQ) Revenue down 5% at Rs 813.75 crore Vs Rs 857.20 crore Net profit down 91% at Rs 14.33 crore Vs Rs 156.51. Recommended a dividend of Rs 30 per share. The record date for the same is July 20.

Brokerage Radar:

CLSA on TATA MOTORS:

Maintain BUY at the Target Price of Rs,450.FCF generation at JLR & India continues to surprise positively.FY21 FCF at Rs5300 crore Despite COVID-related Disruptions. Management Expects strong volume & FCF to Resume in H2FY22.

CITI on TATA MOTORS:

Maintain BUY at the Target price of Rs.395 Domestic Business reported a strong Q4 but JLR performance slightly weak. There are Near-Term Headwinds for Both Biz. Underlying growth Drivers are intact & recovery is seen over H2FY22

NOMURA ON TATA MOTORS:

Maintain REDUCE at the Target Price of Rs.313. Q4 Ahead on lower marketing Spends for JLR.Lower marketing spending seen in near Term.Debt Reduction Positives; Lack of EVs a long-term concern for JLR.

JEFFERIES ON TORRENT PHARMA:

Maintain UNDERPERFORM at the Target Price of Rs.2416.FY22 growth will be Driven by India Rebound in H1.Company expects US to be Stable with launches compensating for price erosion,Estimate of FY21-23 EPS CAGR of 17.2% is Driven by continued Deleveraging.

News Update:

Axis Bank:

Specified Undertaking of the Unit Trust of India to sell 1.95% of the bank’s equity through an Offer for Sale. The initial plan is for the sale of 3.60 crore shares or 1.21% of the total equity with a greenshoe option to sell another 2.20 crore shares or 0.74% of the total equity. The floor price of Rs 680 per share is at a 4.48% discount to Tuesday’s closing price. The OFS opens for non- retail investors today and for retail investors tomorrow.

JSW Energy:

The wholly-owned subsidiary of the company, JSW Hydro Energy, has raised $707 million by allotment of dollar-denominated senior secured notes.

Infosys, Majesco:

Announced strategic collaboration to help joint customers accelerate their digital transformation journey, enabling them to unlock new opportunities, address the demand for personalised customer experiences, operational effectiveness, and digital adoption across the insurance business value chain.

Kirloskar Oil Engines:

Suspended operations at main Kagal Plant, Kagal Plant-II and KMW Kagal Plant-III in Kolhapur to comply with District Collector’s covid order. The plants will remain shut between May 18-23.

Source: Moneycontrol, Livemint,, Bloomberg, Investing, Business Standard

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.

For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.Company-Specific Disclosures Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in , or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person. Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, advisory board member or employee of any company in the analyst’s area of coverage. Country Specific Disclosures India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL Advisory discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL Advisory or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL Advisory or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL Advisory or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL Advisory or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL Advisory or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL Advisory or its associates have not received any compensation for products or services other than investment banking
or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL Advisory or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL Advisory or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL Advisory
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL Advisory or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL Advisory has never been engaged in market making activity for the subject company;
(6) EWL Advisory shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.